UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 21, 2021
Accession Number:
Submission Type:
CIK:
0001106838
Company Name:
Sonnet BioTherapeutics Holdings, Inc.
File Number:
333-252049